Accretive Wealth Partners’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$231K Hold
477
– – 0.05% 153
2026
Q2
$243K Sell
477
-14
-3% -$8.08K 0.06% 156
2026
Q1
$335K Sell
491
-3
-0.6% -$2.07K 0.09% 137
2025
Q4
$282K Hold
494
– – 0.08% 134
2025
Q3
$301K Hold
494
– – 0.09% 125
2025
Q2
$247K Buy
494
+28
+6% +$13.8K 0.08% 133
2025
Q1
$227K Hold
466
– – 0.08% 136
2024
Q4
$219K Hold
466
– – 0.09% 124
2024
Q3
$246K Sell
466
-51
-10% -$25K 0.1% 122
2024
Q2
$225K Buy
517
+1
+0.2% +$457 0.09% 126
2024
Q1
$242K Sell
516
-12
-2% -$5.53K 0.11% 126
2023
Q4
$247K Buy
528
+50
+10% +$23.4K 0.12% 123
2023
Q3
$210K Sell
478
-22
-4% -$9.7K 0.13% 116
2023
Q2
$228K Hold
500
– – 0.14% 107
2023
Q1
$231K Buy
500
+30
+6% +$13.9K 0.15% 107
2022
Q4
$256K Buy
470
+40
+9% +$20.9K 0.18% 104
2022
Q3
$202K Sell
430
-30
-7% -$14.3K 0.15% 102
2022
Q2
$220K Hold
460
– – 0.16% 104
2022
Q1
$206K Buy
+460
New +$190K 0.13% 109

Other funds holding NOC

Accretive Wealth Partners's NOC Position: Q3 2026 in Review

Accretive Wealth Partners held its Northrop Grumman (NOC) position steady in Q3 2026 at 477 shares worth $231K. The position accounts for 0.05% of the portfolio, ranked #153.

Accretive Wealth Partners first reported a position in NOC in Q1 2022 and has held it in 19 quarters since. The position peaked at $335K in Q1 2026. 1,545 funds tracked by Wall St. Rank hold NOC as of Q3 2026.

  • Accretive Wealth Partners held 477 shares of Northrop Grumman worth $231K as of Q3 2026.
  • Accretive Wealth Partners left its Northrop Grumman share count unchanged in Q3 2026.
  • Northrop Grumman made up 0.05% of Accretive Wealth Partners's portfolio in Q3 2026, its #153 holding.
  • Accretive Wealth Partners first reported a position in Northrop Grumman in Q1 2022 and has held it in 19 quarters since.
  • Accretive Wealth Partners's Northrop Grumman position peaked at $335K in Q1 2026.
  • 1,545 funds tracked by Wall St. Rank held Northrop Grumman as of Q3 2026.

Based on Accretive Wealth Partners's 13F filing for Q3 2026, filed 6 Nov 2026.